2.410CHF+0.42%Mkt Cap: —P/E: —1d ago
EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor a…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value13.10M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-744.93K $
Revenue/Share—
Last Price2.410 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.92
EPS (TTM)-0.05
EPS (Forward)—
52W Range
2.30033% of range2.630
52W High2.630 CHF
52W Low2.300 CHF
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-10.41%
ROA-4.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.30M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-6.74M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio8.31
Quick Ratio8.04
Book Value/Sh0.8240 CHF
Cash/Share0.8190 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split0.004:1
Split DateApr 26, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.734.31M
Float—
Insiders41.00%
Institutions2.70%
Technical
SMA 500.7013 (+243.6%)
SMA 2004.232 (-43.1%)
Beta-0.05
S&P 52W Chg18.16%
Avg Vol (30d)2.88K
Avg Vol (10d)1.21K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—